📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study. (2009)

First Author: Ingram W

Attributed to: Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/j.1365-2141.2009.07684.x

PubMed Identifier: 19388935

Publication URI: http://europepmc.org/abstract/MED/19388935

Type: Journal Article/Review

Volume: 145

Parent Publication: British journal of haematology

Issue: 6

ISSN: 0007-1048